> In a trial, the drug offered 100% protection to more than 5,000 women in South Africa and Uganda, according to results announced by Gilead last month.
Is anyone familiar with what happens at the end of trials like these? I assume this was a very late stage of trial - do the participants get a lifetime of treatment? I'm doubtful 43k/yr is anywhere near affordable, amd stopping after a successful trial seems so cruel.